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Cot death or Sudden Infant Death Syndrome (SIDS) is fortunately a rare phenomenon. 
Still it makes up a measurable fraction of the annual deaths among children up to the age 
of three, since the mortality rate in this age group is low. The shock is also that much 
worse when a seemingly healthy child suddenly dies. For several decades one has tried to 
find factors that can trigger and predispose to this condition. Research groups in the US, 
Japan and Norway among others have conducted research on a cellular and molecular 
level in affected infants. The scope has not yet been limited to one field only, but most 
researches base their investigations on a principle proposed by R.J. Wedgewood in 1970, 
the triple-risk hypothesis. Here he proposes that an infant exposed to an external risk 
factor, with a genetic predisposition and at a vulnerable stage in development is at risk of 
SIDS. The external risk factors are fairly well mapped out. Mothers are advised not to 
smoke during pregnancy, and parents told to take care when co-sleeping and to avoid the 
prone sleeping position when putting the child to sleep. The vulnerable stage refers to the 
development of regulatory functions of the nervous system such as breathing, alertness 
and consciousness, and development of the immune system. The most controversial part 
of the hypothesis is the genetic predisposition, and this review will discuss some of the 
studies made on genetic polymorphisms (variants of genes found in the population), more 
specifically the 5-HT (serotonin) related polymorphisms. During the last two decades 
researchers have found anatomical discrepancies in the brainstem of infants affected by 
SIDS and described several polymorphisms related to the serotonergic network in the 
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I had the idea of this review after reading in Brodals "Sentralnervesystemet" about the 
reticular formation. I learned of the connection this part of the brain has to the regulation 
of our basic regulatory functions. After looking this up online I came across a genetic 
researcher at the Department of Forensic Pathology, dr.philos Siri Hauge Opdal, and 
discovered that she among others had published several papers on the subject of 
brainstem serotonin and sudden infant death syndrome. I contacted her and she agreed to 
be my supervisor for this review. I am most grateful for the recommendations, advice and 
time she has given me. The material publised in this field is vast, and I could not have 
done the selection without her help. The data on which this review is written are not 
systematically searched by protocol. My searches and choices on which papers and 
studies to include has however been based on her recommandations and experience on 






























Sudden infant death syndrome, SIDS, is defined as “the sudden unexpected death of an 
infant, with the onset of the fatal episode apparently occurring during sleep, that remains 
unexplained after a thorough investigation, including performance of a complete autopsy, 
and a review of the circumstances of death and the clinical history”(1). 
 
The SIDS-rate, given as number of cases per 1000 live births, differs between different 
countries. This may have several different explanations, as both the age span for using the 
SIDS diagnosis, the SIDS definition, and also the content and use of death-scene 
investigation and autopsy protocols differ between countries (2).  
 














United States 0,53 
 
The table is based on numbers from Hauck et al (2).   
 
 
The etiology of SIDS is most likely multifactorial. In light of this the first triple-risk 
hypothesis was proposed by R.J. Wedgewood and presented at the Bedson Symposium in 
Cambridge, 1970 (3). Rognum and Saugstads (1993) fatal triangle, the triple-risk model 
by Filiano and Kinney (1994) and the multifactorial model of Kahn all emphasize 
approximately the same (4-7). (fig 1). 
                                                                                                   











                                                                                         
Fig 1. The triple risk hypothesis in SIDS. 




According to the triple risk hypothesis, SIDS may occur when an infant at the same time 
is at a vulnerable developmental stage, has a predisposing factor and is exposed to a 
trigger event. The vulnerable developmental stage refers to an age where an infant will be 
at a crucial stage in the development of both the central nervous system and the immune 
system.The age distribution for SIDS peaks between 2 and 4 months of age, although this 
has partly changed into a more even age distribution through the first year of life after the 
SIDS risk-reducing campaigns starting in the 1990`s (8, 9). 
 
Most likely the genetic predisposition for SIDS represent a polygenic inheritance pattern, 
and so far genes involved in regulation of the immune system, cardiac function, the 
serotonergic network, and brain function and development have emerged as the most 
important with regard to SIDS (10). 
 
External risk factors or trigger events for SIDS include prone sleeping position, 
co-sleeping, soft covering, thermal stress, maternal smoking, and slight infection.  
 








converting from prone to supine sleeping position was launched in the 1990`s, in Norway 
the first in 1989. The effect was remarkable, reducing the number of SIDS cases by fifty 
percent in one year (11). Similar results have been seen elsewhere in Europe and in the 
US. 
 
A Norwegian study comparing numbers from two six-year periods before and after the 
supine sleeping campaign found a strong reduction in total number of deaths (12). The 




 months of life, and the number of deaths 
during the first two months of life now make up a much larger percentage of total deaths 
than previously ( from 4,5% to 18%). More infants were found dead in a co-sleeping 
position than before the campaign, an increase from 7% to 35%. The risk increase was 
found among the youngest infants, during the two first months of life. Also in this study 




Unsafe co-sleeping is another trigger event for SIDS. Arnestad et al published a paper on 
changes in epidemiological patterns for SIDS cases in south-eastern Norway in 2001 (9). 
According to their findings, an increase was seen in the number of infants found dead 
while co-sleeping in the late 1990’s. This may be due to an increased risk of SIDS with 
co-sleeping, or it might refer to a general increase in the number of infants co-sleeping 
with a parent. The study also disclosed a positive relationship between co-sleeping at 
time of death and maternal smoking during pregnancy. 
 
 
Thermal stress (increased temperature in the child’s sleeping environment) has been 
revealed as a possible risk factor, mostly during interviews with parents of SIDS victims. 
One of the first to argue this was Stanton (13).He investigated cases of cot death in the 
Oxford and Scarborough areas from 1981 to 1984. The most important finding was that 
almost all the investigated cases had extra risk factors for overheating at the time of 
death. The risk factors being a warm sleeping environment, overdressing/wrapping, 
victim hot/sweaty when discovered, or terminal infective illness (13).  
 
There are also studies indicating that a raised temperature has a negative impact on 
respiratory reflexes during hypoxia. An analysis published by Guneroth and Spiers in 
2001 based on publications on thermal stress in infants concludes that a strong 








prolonged apnoea (14). 
  
Another well-known external risk factor for SIDS is maternal smoking during pregnancy. 
In a Swedish study published in 1990, Haglund and Cnattingius found an almost fifty 
percent increased risk of SIDS in infants whose mothers smoked between 1 and 9 
cigarettes per day, and an almost tripled risk if the mothers smoked more than 10 
cigarettes per day (15). Another paper published in 1996, by Blair et al., show similar 
results with the risk of SIDS increasing with the number of cigarettes smoked (16). 
 
In relation to infection being an external risk factor, about half of SIDS victims show 
signs of slight infection prior to death. Several studies have looked into this. A case 
control study from 1989 of pulmonary immunoglobulin levels in post-mortem lung 
lavage samples from infants dying of SIDS showed raised levels of IgM, IgG, and to a 
lesser extent IgA, when compared to controls dying from non-pulmonary causes (17). 
Vege et al. published a paper in 1995 where they reported elevated levels of the cytokine 
IL-6 in the CSF (cerebrospinal fluid) in SIDS victims compared to controls (18). They 
proposed a mechanism in which the raised levels of cytokines trigger a pathological 
response in the brainstem of predisposed infants. This was followed up by a study 
published in 2009 with findings of abnormal IL-6R (IL-6 receptor) expression in the 
arcuate nucleus of SIDS infants, further suggesting an abnormal infectious response in 
the brainstem (19). 
 
Kinney and co-workers have proposed that “SIDS is a disorder of homeostasis in which 
the infant with an underlying brainstem abnormality cannot adjust to or defend against 
asphyxia or other metabolic challenges that result from life-threatening events during 
sleep” (20). 
 
Two approaches to the verification of the brainstem abnormality hypothesis are 
investigations of genetic polymorphisms in genes involved in the serotonergic network in 
cases of SIDS, searching for a possible genetic vulnerability, and the post mortem 
examination of brainstem tissue from SIDS victims, also here with the focus on 
serotonergic pathways in the brainstem. The rest of this review will focus on these two 







































The brainstem and its structures 
 
 
The brainstem controls many of our primary functions, including respiration, circulation 
and consciousness. The anatomical area defined as the brainstem can be divided into 
three structures, the medulla oblongata, the pons and the mesencephalon, with the 
medulla oblongata being the most inferior, situated on top of the medulla (spinal cord) 
and the mesencephalon the most superior, connecting with the diencephalon (midbrain). 
 
The brainstem has a hollow central canal going through the three parts vertically, 
expanding into a cavity (the fourth ventricle) on passing the pons. This canal contains the 
cerebrospinal fluid (CSF) and runs from the base of the spine to the cerebral cortex (21). 
 
Another structure found in all three parts of the brainstem is the reticular formation. This 
is a diffuse network connecting both upwards to the cerebrum and cerebellum and 
downwards to the spine. The reticular formation is centrally situated in the brainstem, 
filling out the parts not occupied by cranial nerve nuclei and motor and sensory 
pathways. Different functions can be found according to structural position. An example 
is the ventral respiratory group (VRG) situated in the ventrolateral, superior part of the 
medulla oblongata. The neurons in this area have been found to contain what we believe 
to be the rhythm generator for respiration, the pre-Botzinger complex. Though probably 
one of the most important, the VRG is only a part of the complex system controlling 
respiration.  
 
As previously mentioned the brainstem also contains the nuclei of all 12 cranial nerves, 
with the exception of 1 and 2 which are located in the cerebrum. Axons (nerve threads) 
connecting the cerebrum and cerebellum can also be found in the pons. They form 
bundles or stalks called the crus cerebri and brachium pontis (22). 
 
The brainstem is also thought to influence the state of wakefulness/consciousness. These 
functions can also be related to the reticular formation. In 1949 Moruzzi and Magoun 
found a cortical arousal response to electrode stimulation of the reticular substance in 
animal experiments (23). This was recorded through electroencephalography (EEG) 
readings showing a shift in brainwave activity. Moruzzi and Magoun proposed on the 
background of their findings, that the brainstem holds a mechanism for activation of the 




































Serotonin and its properties 
 
 
Serotonin, or 5-hydroxytryptamine (5-HT), is a biological mediator produced within the 
body’s cells from the amino-acid tryptophan. It was originally discovered as a 
vasoconstrictor, and the name sero-tonin was therefore given. 
 
In sense of volume, the majority of bodily serotonin can be found in enterochromaffin 
cells imbedded in the gut lining. The release of serotonin from these cells increase 
peristaltic movement and triggers vomiting when an irritant is introduced into the 
stomach. In addition some serotonin can also be found in the myenteric plexus (a 
peripheral nerve plexus controlling the gut) where its function is to transmit excitatory 
signals (24). 
 
Serotonin is an important neurotransmitter in the central nervous system (CNS). The 
discovery of this dates back to the beginning of the 1950`s when J.H. Gaddum showed 
the antagonist effect of LSD (a hallucinogenic drug produced from the fungus ergot) on 
serotonin in peripheral tissue. Knowing the hallucinogenic features of LSD, the thought 
that serotonin might also have a function within CNS was formed (25).This idea was also 
supported by an article presented by B.M.Twarog and I.Page in 1953, showing the 
existence of serotonin in the mammalian brain (26).  
 
Because 5-HT is a hydrophilic substance it cannot pass the blood-brain barrier. As a 
consequence of this 5-HT must be produced internally in the brain in order to have access 
and effect within the CNS (25). 
 
The first step in the synthesis of 5-HT is uptake of tryptophan by neuronal cells. From 
tryptophan the enzyme tryptophan hydroxylase produce 5-hydroxytryptophan. A 
non-specific amino-acid decarboxylase then synthesizes the final product 
5-hydroxytryptamine (5-HT). The regulating steps in this process are tryptophan 
availability and tryptophan hydroxylase activity (25). 
   




















In the brain, serotonin is released into the synaptic cleft, where it either will bind to a 
receptor, or be subject to reuptake through the serotonin transporter (5-HTT) and further 
degradation by monoamine oxidase A (MAO-A). Alternatively serotonin can bind to auto 
receptors at the presynaptic surface and here regulate the release of serotonin by a 
feedback mechanism (fig 5).    


















The neuroanatomy of 5-HT in the brain has been shown to consist of a medullary system, 
mainly in rostral and caudal parts of the brainstem (e.g. raphe, extra raphe and ventral 
surface).The cell bodies project upwards to the cerebral cortex, thalamus, hypothalamus, 
basal ganglia, hippocampus and amygdale, and downwards to other sites in the 
brainstem, cerebellum and spinal cord. Their positioning reflects connections to different 
functions. The rostral extension is connected to regulation of arousal, cognition, mood, 
motor activity and cerebral blood flow. The caudal part modulates cardiovascular 
function, respiration, chemo sensitivity, thermoregulation, upper airway reflexes, motor 














The serotonin receptor family consists of several subtypes, all acting through G-protein 
and second-messenger systems, with the exception of 5-HT3, which is a ligand-gated ion 
channel. At least seventeen subtypes have been recognized so far. They are divided into 
the 5-HT1, 5-HT2, 5-HT3 and 5-HT4-7 families, with the subtypes classified under each 
family (27). Most subtypes can be found within the CNS, with 5-HT1 being the most 
CNS specific. The relevance of the different subtypes is shown through the fact that they 
display different responses to the same substance. As an example, the 5-HT1 receptor 
subtype inhibits neuronal firing, while the 5-HT2 receptors of CNS have an excitatory 
effect (24). 
 
The neurotransmitter effect is conveyed by the release of serotonin from axonal varicoses 
(axonal swellings within the target area), diffusion, and further binding to receptors at 
postsynaptic terminals or extra synaptic receptors. This form of neurotransmission is 
called volume transmission and is different from the fast and precise transmission from 
pre to post synaptic terminal where the distance of diffusion is shorter. Volume 
transmission is typical to the modulating effects of metabotrope receptors which the 
above mentioned G-protein serotonin receptors are examples of. This effect is slow, 





The serotonin transporter 
 
 
The serotonergic network is under bottleneck control by the serotonin transporter 
(5-HTT), which regulates the level of available serotonin in the synaptic cleft between the 
cells. 5-HTT is a trans-membrane protein specific to serotonin, although related to the 
other monoamine transporters, DAT (dopamine transporter) and NAT (noradrenalin 
transporter) transporters (28).
 
5-HTT is coded for by a single gene located on 
chromosome 17. Several polymorphisms affecting the expression and function of 5-HTT 
have been described, the most important is a length variation in the promoter region of 
the gene. This is a deletion/insertion polymorphism which gives rise to two allelic 
variants, denoted short (S) and long (L), consisting of 14 and 16 repeats respectively. It 








of the gene, which results in a more effective reuptake of serotonin, and thus a lower 














Foetal development of 5-HT in the medulla 
 
Kinney’s research group at Harvard Medical School have analyzed brainstem tissue 
collected from 30 different stages throughout foetal development into infancy (30).Their 
findings suggests an appearance of the first 5-HT neurons early in the first trimester, and  
that a mature pattern is appearing at 20 weeks of gestation, after which the only change 
seemed to be qualitative in the form of subtype differentiation and internal migration 
within the 5-HT system, with the total number of neurons being unchanged. This process 
however continued throughout the span of their data set, meaning that the serotonergic 
network is not fully developed at birth. Thus the vulnerable developmental period seem 
to span from the embryonic period throughout the first year of infancy.   
 
These findings are important as confirmation of the existence and location of a medullary 
5-HT pathway, and as a stepping stone towards mapping the significance of its effect on 
homeostatic functions. Pinpointing the time of development is also important as it allows 
more fine-tuned research into which factors affect the foetus at different times of 
gestation, and why defects in the 5-HT system occur. In their paper , Kinney et al. 
underline the importance of exogenous stressors affecting the foetus at an early time in 
gestation when the mother is not aware of the pregnancy and therefore do not take the 
precautions (e.g. exposure to nicotine, alcohol, SSRI’s) as she later on would when 














Brain stem abnormalities in SIDS 
 
 
The brainstem hypothesis can be traced back to 1987 when Hunt and Brouillette 
speculated that SIDS was related to a brainstem abnormality in the neuroregulation of 
cardiorespiratoy control (31). This was at the time a consolidated hypothesis and its 
position is even more strengthened today. 
 
Hannah Kinney and her research group at Harvard Medical School has tried to approach 
the pathology behind SIDS through the brainstem hypothesis, more precisely put, that a 
defect in the brainstem cause a diminished response to hypercapnia and hypoxia and can 
therefore possibly lead to asphyxiation under periods of stress ( prone sleeping position, 
soft bedcovering, infection, overheating). Their line of research has focused on the 5-HT 
medullary pathway, its location, development and possible abnormalities detected 
between SIDS victims and controls (27). 
 
Kinney and her colleagues at Boston Childen Hospital have since 2000 published several 
papers on three independent datasets, comparing SIDS victims to controls in respect of 
brainstem abnormalities. One of the papers published on the first of these three data sets 
was published in the Journal of Neuropathology & Experimental Neurology and tested 
the hypothesis of 1) decreased serotonergic receptor binding in the arcuate nucleus, and 
2) an increase or decrease of binding in the raphè obscurus in SIDS victims compared to 
controls (32). Both regions showed decreased binding compared with controls. In 
addition decreased binding was also found in the nucleus gigantocellularis, nucleus 
paragigantocellularis lateralis and intermediate reticular zone.  
 
The abovementioned results spurred further research into medullary serotonergic 
abnormalities. In 2003 Kinney and colleagues published a new paper, this time from a 
dataset in a high risk group, the Northern Plains Indians (33). In this study they presented 
three hypotheses: 1) that there would be a decreased serotonergic receptor binding on 
average in SIDS victims compared to controls, 2) also, there would be a decreasing 
binding in SIDS victims with increasing age compared to controls with no such decrease, 
and 3) a serotonergic receptor binding decrease in SIDS victims correlate with maternal 
cigarette and/or alcohol use during pregnancy, linking these as teratogens in respect to 
abnormalities in the medullary serotonergic network. The material was collected from 23 
SIDS victims and 6 controls. 
 








in the arcuate nucleus of SIDS victims when compared to controls. Decrease in binding 
with increasing age was found in the nucleus gigantocellularis, nucleus 
paragigantocellularis lateralis, intermediate reticular zone and raphè dorsalis. This decline 
in binding was not found in the control group. A significantly lower mean binding was 
found in mothers who smoked compared to non-smokers. Only a marginal lowering in 
binding capacity was found when comparing mothers that drank alcohol to those who did 
not.  
 
A third dataset consisting of 31 SIDS cases and 10 controls investigated 5-HT cellular 
defects related to the previously found receptor binding abnormalities (34).The authors  
measured 5-HT neuron count, density, 5-HT receptor binding density (5-HT1A) and 
5-HTT binding density, all samples were taken from the medulla. A significantly higher 
number and density of 5-HT neurons were found in the samples taken from the raphè, 
extraraphè and ventral surface of both rostral and mid-medulla levels of SIDS cases when 
compared to samples from controls. Binding density to 5-HT 1A were significantly 
decreased in SIDS cases compared to controls (not in the principal olivary nucleus). In 
addition to this they found a significantly lower binding density in SIDS males when 
compared to SIDS females. This is an interesting observation as males make up the 
majority of SIDS victims. 
 
Regarding the serotonin transporter, 5-HTT, there was not an absolute decrease, but a 
relative binding decrease in relation to number of neurons was observed in the raphè 
obscurus of SIDS cases when compared to controls.  
 
The study also reported findings to support the external risk part of the triple risk 
hypothesis. 97% of the SIDS victims were reported to have a minimum of 1 abnormal 
risk factor, the risk factors tested being 1) male gender, 2) prematurity, 3) prone sleeping 
position, 4) face down position, 5) bed sharing, 6) sick with minor illness last week 
before death (34). 
 
The cause for this increased number and density of 5-HT neurons have been speculated to 
be compensatory, meaning the increased number is caused by a deficiency of 5-HT and 
therefore during development the brain compensates through increasing the number and 
density of neurons. The composition of different subtypes of 5-HT neurons was also 
found to differ between controls and SIDS victims in this study. In the latter, more 
granular and less multipolar 5-HT cells were identified, the granular cells being a more 
rudimentary form than the multipolar. The significance of this is unclear, but seen in the 








speculate on a dysfunction of these cells causing a greater number and density of 5-HT 
neurons in an attempt to compensate for 5-HT deficiency. 
  
On the second of February 2010, JAMA published a paper by the same research group 
(35). This latest paper were of significant findings of decreased medullary 5-HT and 
TPH2 (a precursor of 5-HT) in SIDS victims, compared to controls. 26 % lower 5-HT 
levels in the PGCL (nucleus paragigantocellularis lateralis) and raphè obscurus, and 22% 
lower TPH2 in the raphè obscurus. They did however not find excess levels of the 
degradation metabolite of 5-HT, 5-HIAA, indicating a low production rather than an 
excess degradation of 5-HT. In this study a control group and a group of hospitalized 
infants with chronic oxygenation disorders were used for comparison. In the hospitalized 
group, levels of 5-HT were higher than the SIDS group and the TPH2 levels lower.  
They also compared 5-HT1A - receptor binding in the brainstem, and found reductions in 
the SIDS group compared to controls in the hypoglossal nucleus, solitary tract nucleus 
and dorsal motor nucleus of vagus. Furthermore a relative decrease in 5-HT receptor 
binding in PGCL, gigantocellularis and intermediate reticular zone with increasing age of 






























Genetic investigations of the serotonergic network in SIDS  
 
 
A review on implicated genes in SIDS was published in 2007 by Weese-Mayer et al. (36) 
reflecting the last two decades of research in this field. Five groups of genes were 
identified as candidates. 1) genes for ion channel proteins, 2) genes regulating the 5-HT 
transporter, 3) genes involved in embryologic development of the autonomic nervous 
system, 4) genes for nicotine metabolizing enzymes and 5) genes regulating 
inflammatory, thermal and hypoglycaemic processes.  
 
In a summary on genes involved in SIDS from 2011, Opdal and Rognum highlight three 
areas of interest, namely cardiac function, the immune system and 5-HT network related 
genes (37). They also emphasize a polygenetic inheritance pattern as a predisposing 
factor as opposed to one single gene defect as seen in for instance long QT-syndrome or 
MCAD (medium-chain acyl-coenzyme A dehydrogenase deficiency). 
 
As mentioned earlier, the serotonin transporter (SERT or 5-HTT) is responsible for 
serotonin reuptake from the synaptic cleft, and thus responsible for the regulation of 
available serotonin in the cleft. The findings of reduced serotonin levels and receptor 
binding in cases of SIDS (32-35) may indicate that also specific variants of the genes 
encoding the different components involved in the serotonergic network may be involved 
in SIDS.   
 
The first study regarding this was a Japanese study investigating an insertion/deletion 
polymorphism in the promoter of the 5-HTT gene in 27 SIDS cases and 115 controls 
(38). This study revealed an association between the L-allele and SIDS, suggesting a 
lower level of available serotonin in SIDS victims compared to controls. 
 
Similar results were also presented by Weese-Mayer et al. (39) in a cohort study of 84 
SIDS cases in the US published in 2003. They showed a positive association between L/L 
genotype and L-allele and SIDS cases. They also found a negative association between 
the S/S genotype and SIDS, thus indicating a reduced risk of SIDS in infants carrying the 
S/S genotype.  
 
Furthermore this group found an association to another polymorphism involved in 
regulating 5-HTT expression. Having a 12 versus a 10 repeat sequence in a VNTR in 








(40). The 12 repeat haplotype was more common among Afro-Americans, both SIDS 
victims and controls compared to the Caucasian group. The latter has however not been 
confirmed by later studies. 
 
In 2008 Marzano et al. published results of a study of 20 SIDS cases and 150 controls 
looking into several polymorphisms including the promoter and intron 2 VNTRs of the 
5-HTT gene (41). They found a significant difference in distribution of genotype L/L and 
allele L between the SIDS group and the control group. The intron 2 polymorphism was 
also increased in the SIDS group but the findings were not significant.  
 
 
This was again confirmed in a study by Opdal and Rognum, also in 2008 (42). With 
larger groups of both SIDS and controls, 163 and 243 respectively, they also investigated 
polymorphisms in the promoter and intron 2 of the 5-HTT. They found a tendency for the 
L allele and the L/L genotype to be more frequent in SIDS cases than in controls (p= 0.05 
and 0.07, respectively). In addition they noticed a different distribution of genotype in 
regards to the infants sleeping position at the time of death. More victims found in other 
sleeping positions than prone had the L/L genotype, and more S/S victims were found 
prone, suggesting perhaps that the L/L victims were less dependent on this known risk 
factor, and therefore more intrinsically predisposed than victims found in the prone 
position. Regarding the intron 2 polymorphism there were no differences between the 
groups (42). 
 
In contrast to the abovementioned results two studies have later found no significant 
difference in allelic or genotype distribution between SIDS and control groups.  
Haas et al. investigated 145 SIDS cases and 58 controls, but found contradictory results 
with an increased frequency of both L/L genotype and L allele in the control group as 
opposed to the SIDS group (43). Paterson et al. investigated 179 SIDS cases, 139 dead 
controls and 299 living controls and also found no significant increase in frequency of the 
L/L genotype or the L allele in their SIDS population (44). They also tested the link 
previously described between sleeping position and genotype/allele, but did not find any 
significant difference in distribution (44). 
 
Weese-Mayer et al. has also used the same dataset (39, 40, 45) to investigate a 3`UTR 
polymorphism in the 5-HTT. No association was found between haplotype distribution of 
the 3`UTR polymorphism and SIDS (45). 
 








5-HT receptors occurring in the brainstem. In relation to SIDS two such studies have 
investigated the HTR1A and HTR2A (genes coding for the 1A and 2A 5-HT receptors) 
(46, 47). In both cases they found no specific gene polymorphism more common among 






































This review has tried to summarize two strings of research within the brain stem 
serotonin hypothesis in SIDS. The immunohistochemical studies have revealed a definite 
pathology in relation to distribution of 5-HT networks and activity in the brain stem of 
SIDS victims. The question is what direct consequence this has to the physiology of the 
infant. In looking at polymorphisms of genes regulating the amount of 5-HT we try to 
come closer by determining the functional consequences of these seen anatomical 
discrepancies. A decrease of 5-HT can be explained by increased activity of the 5-HTT. 
How reliable are the results, especially in light of contradictive findings? 
 
SIDS is, when speaking in absolute numbers, a rare disorder, and access to research 
material is in a lot of cases difficult on the background of this. The ethical and moral 
dilemmas of getting access to the available material by getting permission from grieving 
parents also makes the accumulation of data difficult in some countries. While we in 
Norway have a law securing that all children under the age of 18 dying of an unknown 
cause go through an autopsy, some countries like the UK have laws demanding all 
material taken at autopsy be returned to the body, making it impossible to retain samples 
for research. All the studies in this review are case-control studies. A randomization 
process is therefore in these cases not possible. However, in the process of analyzing 
results very few have mentioned blinding the analysis process or mentioned this as a 
possible systematic bias to their results. 
 
The immunohistochemical studies have been extensive and meticulous, however they are 
a time consuming way of conducting research. The downside in this is a limited number 
of samples being investigated. The first dataset from 2000 (32) has 52 SIDS cases and 27 
controls. To their benefit they have blinded the analysis of measuring 5-HT binding, 
selecting 19 brainstems to be analyzed, however 19 in itself is a fairly low number to 
base calculation of means on. 
 
The Northern Plains study from 2003 (33) brings reliability to the previous study and 
confirm the results but cannot be generalized outside the American Indian population. 
Also in the 2006 (34) and 2010 (35) publications the consistent findings of abnormalities 
in 5-HT neuron density, distribution and binding sites are confirmed. Combined they 
yield a strong likelihood of such an abnormality actually existing. Their findings on 












The Narita study from 2001 (38) has a relatively small sample but concentrates on one 
ethnic population only. Although small this means the results can be transferred to a 
genetically identical population The Weese-Mayer study (39) has a larger sample of both 
Caucasian and African-American cases and the findings are significant with a p-value of 
0.022 in regards to genotype and 0.005 for allele. This reflects a strong significance, the 
transference value to the general population is however weakened by the mixing of two 
ethnic groups.  
 
The Marzano study (41) is criticized for a low number of SIDS cases, only 20, and in 
addition has a genotype and allelic distribution in their control-group that differ from the 
control groups in other studies of same ethnic background ( 36, 39, 41-43). It is difficult 
to speculate how this has come about, but is does unfortunately make it more difficult to 
compare to similar studies made. 
 
The Opdal and Rognum study (42) has by far the largest sample among the three studies 
showing significant differences between SIDS and control groups. The significance is 
strongest here for the allelic association with a p-value of 0.05, with the near significant 
genotype association at p= 0.07. This sample is based upon Caucasians only.  
 
The Haas group (43) has a large SIDS group of 145 cases, but only 58 control cases and 
is also based on a Caucasian population only. 
 
The study by Paterson et al. (44) has a large, multi-ethnic sample in both SIDS and 
control group and their findings are non-significant for difference in allelic and genotype 
distribution in the promoter of 5-HTT, also in the case of association to sleeping position. 
A non-significant finding in such a large sample is curious when looking at former 
studies made. A possible explanation could be that mixing of ethnicities cloaks the 
existing genetic differences. It must also be argued that as always a lack of a significant 
finding does not exclude that such an association exists.  
 
Opdal and Rognum (42) suggest an indirect link connected to polymorphisms of genes 
affecting the 5-HTT polymorphism itself. Also mentioned and interesting is the discovery 








(r225531) within the VNTR of the 5-HTT, giving an LA and a LG, and the same for the S 
allele, with the LG allele yielding the same expression of the gene as the S allele, namely 
reduced levels of 5-HTT mRNA leading to lower activity while only the LA allele gives 
increased activity (48). This could if correct explain why studies have showed 
contradictive findings in relation to allelic and genotype distribution but is at this time 
only speculative.  
 
As previously mentioned in the introductory chapters, a multifactorial approach must be 
taken when discussing SIDS. The combination of a predisposition, a vulnerable 
developmental period and a trigger event still stands as the reasonable approach to this 
enigma. What this predisposition consist of is still an important field of research, but 
considering the histopatological findings and the genetic studies, the brain stem 
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